Rechercher | Webyourself Social Media Platform

Aishwarya Doiphode Ajout d’un nouvel article Health
2024-08-08 09:02:57 -

North America Leads in Retinal Biologics Market Growth
Retinal Biologics Market Introduction & Size Analysis: Retinal biologics are bioengineered substances administered directly into the eyes to treat persistent retinal disorders. These biologics are typically derived from living organisms, such as microbes, animal cells, or plant cells. Notable examples include Eylea, Lucentis, Humira, and Macugen. The global rise in retinal disorders, such...

0 Commentaires 0 Parts 363 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kiran Pawar Ajout d’un nouvel article Health
2024-09-19 07:52:22 -

Retinal Biologics Market Share Trends: Future Growth and Opportunities
The global Retinal Biologics Market Share was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy,...

0 Commentaires 0 Parts 228 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kiran Pawar Ajout d’un nouvel article Health
2024-09-17 09:17:17 -

Retinal Biologics Market Size Forecast 2024: Trends and Analysis
The global Retinal Biologics Market Size was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy,...

0 Commentaires 0 Parts 266 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sunil Kumar Ajout d’un nouvel article Health
2024-09-23 13:39:53 -

The Future of the Retinal Biologics Market Size: Trends to Watch
The Retinal Biologics Market Segment, valued at USD 22.5 billion in 2023, is projected to expand to USD 49.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. Retinal biologics are innovative therapeutic agents used to treat various retinal disorders, including age-related macular degeneration (AMD), diabetic retinopathy, and...

0 Commentaires 0 Parts 252 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kiran Pawar Ajout d’un nouvel article Health
2024-09-12 10:15:30 -

The Retinal Biologics Market in 2024: Trends and Predictions
The global Retinal Biologics Market was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy, alongside...

0 Commentaires 0 Parts 345 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kiran Pawar Ajout d’un nouvel article Health
2024-09-12 10:15:41 -

The Retinal Biologics Market in 2024: Trends and Predictions
The global Retinal Biologics Market was valued at USD 22.5 billion in 2023 and is expected to reach USD 49.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. The market's growth is propelled by the increasing prevalence of retinal disorders, such as age-related macular degeneration (AMD) and diabetic retinopathy, alongside...

0 Commentaires 0 Parts 309 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!